PubMed Health⌕ Search

PubMed · 2102033

[Mini-mapping ECG].

Abstract

63 patients with clearly defined myocardial infarction and an echocardiographically evident akinesia and hypokinesia, respectively, were examined by means of the echocardiography, the conventional ECG (12 leads) and the classical mapping ECG (69 leads). From the latter a mini-mapping ECG (12 chest electrodes) was led. IN 20% of the cases we did not find an accordance between the classical mapping ECG and the mini-mapping ECG in the localization of an echocardiographically proved disturbance of the excursion of the heart wall. In these cases small circumscribed myocardial lesions were concerned which were located particularly postero-inferiorly, the proof of which restricted itself to a thoracic surface less than 54-108 cm2 in the classical mapping ECG. But in larger lesions of the myocardium already the conventional ECG shows correct diagnostic statements. The coordination of the myocardial infarctions to the individual parts of the heart can be performed on the basis of a topographic mapping ECG card. A quantitative estimation of the electrocardiographic findings is not possible with the mini-mapping-ECG. The diagnostic valency of the mini-mapping-ECG is to be arranged only in the third place after the classical mapping ECG and the conventional ECG!

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

K Kehl. 1990-12-15. [Mini-mapping ECG].. https://pubmed.ncbi.nlm.nih.gov/2102033/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Update on PPAR agonists: the clinical significance of FIELD and PROACTIVE.

The peroxisome proliferator-activated receptor (PPAR) family of genes plays a major role in metabolic regulation. Unfortunately, the results of two recent, large event trials of PPAR agonists have been mixed. High rates of crossover to statin use confound the interpretation of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) trial, which found a less than expected reduction in coronary and stroke events with fenofibrate. Of concern, nonsignificant increases in coronary and sudden deaths, thrombotic events, and pancreatitis occurred in the fenofibrate group. The PROspective pioglitAzone Clinical Trial In macroVascular Events (PROACTIVE) also found a reduction in coronary and stroke events with pioglitazone compared with placebo in a population with diabetes and cardiovascular disease, but this benefit was counterbalanced by an increase in congestive heart failure as well as symptomatic edema. Further research is needed to determine the role of PPAR agonists in the prevention of cardiovascular disease.

Coronary Disease↗

Depressive symptoms and sex affect completion rates and clinical outcomes in cardiac rehabilitation.

Symptoms of depression are often seen in patients with coronary heart disease. Symptoms appear more commonly in women and are negatively associated with measures of cardiovascular health. Using multiple logistic regression analyses, the authors evaluated the independent effects of depression (as measured by the Beck Depression Inventory [BDI-II]) and sex on cardiac rehabilitation (CR) completion. In addition, in those who completed CR, the authors evaluated whether depressive symptoms and sex affected clinical outcomes. Women as well as participants with enrollment BDI-II scores > or =14 had significantly higher rates of CR noncompletion. Patients with BDI-II scores > or =14 who completed CR achieved significant improvements in lipid profile, body mass index, and exercise capacity regardless of sex. Women and individuals with BDI-II scores > or =14 are at risk for CR noncompletion and should be encouraged to complete CR, because cardiovascular benefits comparable to those seen in men and individuals with low BDI-II scores were achieved when these patients completed the CR program.

Coronary Disease↗